LABD vs VIG

ALABD

BVIG

Measures won1–5VIG wins · of 6 · 5Y

$10,000 · 5Y$16,243VIG · LABD $391

Lowest cost0.04%VIG · $4 on $10k

Most income6.35%LABD · $635 on $10k

Smallest drop−7.9%VIG · worst fall in 1Y

Held in common[…]LABD and VIG

LABD

VIG

Direxion Daily S&P Biotech Bear 3X ETF · $61MVanguard Dividend Appreciation ETF · $109B

−68.2%3 years · per year$322 · $16,669+18.6%

−47.7%5 years · per year$391 · $16,243+10.2%

1.08%Expense ratio$108 · $4 on $10k · lower wins0.04%

6.35%12-mo yield$635 · $150 on $10k1.50%

−80.6%Worst dropSmaller wins−7.9%

90.5%VolatilityLower wins10.8%

1–5VIG wins

$10,000 · 5 yearsAll three, one scale

Shared top holdingsLABD · VIG

They share no top holdings, or holdings aren’t on file […]

Held in common[…]

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Three

5Y3 funds

#
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.50%	−0.4%	+12.1%	+14.3%	+18.6%	+10.2%	−7.9%	$109.1B
2	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.35%	−7.5%	−64.9%	−75.7%	−68.2%	−47.7%	−80.6%	$61M
3	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.27%	−0.1%	+9.6%	+12.9%	+23.5%	new	−9.7%	$39.5B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Three

5Y3 funds

#
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.50%	−0.4%	+12.1%	+14.3%	+18.6%	+10.2%	−7.9%	$109.1B
2	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.35%	−7.5%	−64.9%	−75.7%	−68.2%	−47.7%	−80.6%	$61M
3	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.27%	−0.1%	+9.6%	+12.9%	+23.5%	new	−9.7%	$39.5B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

LABD vs VIG

LABD

Direxion Daily S&P Biotech Bear 3X

$391

VIG

Vanguard Dividend Appreciation

$16,243

MeasureLABDVIG

Fee1.08%0.04%

Cost on $10k a year$108$4

Yield6.35%1.50%

5 years, per year−47.7%+10.2%

3 years, per year−68.2%+18.6%

Worst drop · 1Y−80.6%−7.9%

Volatility · 1Y90.5%10.8%

5–1measures won
VIG first

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

DGRO vs VIG

YTD

iSharesDGRO

+16.6%

VIGVanguard

+12.1%

+16.6%Year to date+12.1%

1.9%Yield1.5%

$44.9BAssets$109B

2–0DGRO wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$42.6BAssets$46.8B

1–1level

End-of-day Nov 6, 2026

Overlap: LABD, VIG, CGDV

Today

29.4%most shared, VIG and CGDV

LABDVIGCGDV

LABD—[…][…]

VIG[…]—29.4%

CGDV[…]29.4%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$527most kept, LABD

LABD$635 − $108 = $527

VIG$150 − $4 = $146

CGDV$127 − $33 = $94

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee